Pharmacological animal models of Tourette syndrome

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 6, 2013, Pages 1101-1119

  Bronfeld, Maya ^a   Israelashvili, Michal ^a   Bar Gad, Izhar ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

Animal models; Basal ganglia; Dopamine; GABA; Limbic system; Motor system; Motor tics; Pharmacology; Primate; Rat; Sensorimotor gating; Stereotypic behavior; Striatum; Tourette syndrome

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; AMPHETAMINE; BICUCULLINE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; NEUROLEPTIC AGENT; NORADRENALIN; PICROTOXIN; SEROTONIN; SEROTONIN AGONIST; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ANIMAL MODEL; ATTENTION DEFICIT DISORDER; BASAL GANGLION; COMORBIDITY; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; DRUG EFFECT; GABAERGIC SYSTEM; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPERACTIVITY; MICROINJECTION; NEUROANATOMY; NEUROBIOLOGY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSORY GATING; STEREOTYPY; TIC; ANIMAL; BRAIN CORTEX; DISEASE MODEL; DRUG EFFECTS; NERVE TRACT; PATHOLOGY; PHYSIOLOGY; SYNAPTIC TRANSMISSION; TOURETTE SYNDROME;

ANIMALS; BASAL GANGLIA; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; HUMANS; NEURAL PATHWAYS; NEUROTRANSMITTER AGENTS; SYNAPTIC TRANSMISSION; TOURETTE SYNDROME;

EID: 84888115694     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2012.09.010     Document Type: Review

References (250)

1. Ackermans L., Temel Y., Cath D., van der L.C., Bruggeman R., Kleijer M., Nederveen P., Schruers K., Colle H., Tijssen M.A., Visser-Vandewalle V. Deep brain stimulation in Tourette's syndrome: two targets?. Movement Disorders 2006, 21:709-713.
2. Albin R.L., Koeppe R.A., Bohnen N.I., Nichols T.E., Meyer P., Wernette K., Minoshima S., Kilbourn M.R., Frey K.A. Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology 2003, 61:310-315.
3. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends in Neurosciences 1989, 12:366-375.
4. Alexander G.E., Crutcher M.D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends in Neurosciences 1990, 13:266-271.
5. Alexander G.E., DeLong M.R. Microstimulation of the primate neostriatum. II. Somatotopic organization of striatal microexcitable zones and their relation to neuronal response properties. Journal of Neurophysiology 1985, 53:1417-1430.
6. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience 1986, 9:357-381.
7. Alsene K.M., Carasso B.S., Connors E.E., Bakshi V.P. Disruption of prepulse inhibition after stimulation of central but not peripheral alpha-1 adrenergic receptors. Neuropsychopharmacology 2006, 31:2150-2161.
8. Alsene K.M., Fallace K., Bakshi V.P. Ventral striatal noradrenergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine. Neuropsychopharmacology 2010, 35:2346-2356.
9. Alsene K.M., Rajbhandari A.K., Ramaker M.J., Bakshi V.P. Discrete forebrain neuronal networks supporting noradrenergic regulation of sensorimotor gating. Neuropsychopharmacology 2011, 36:1003-1014.
10. American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders IV - Text Revision (DSM-IV-TR). Washington DC: American Psychiatric Association.
11. Anand A., Charney D.S. Norepinephrine dysfunction in depression. Journal of Clinical Psychiatry 2000, 61(Suppl. 10):16-24.
12. Aoki C., Go C.G., Venkatesan C., Kurose H. Perikaryal and synaptic localization of alpha 2A-adrenergic receptor-like immunoreactivity. Brain Research 1994, 650:181-204.
13. Arnsten A.F., Scahill L., Findling R.L. alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data. Journal of Child and Adolescent Psychopharmacology 2007, 17:393-406.
14. Azizi H., Ranjbar-Slamloo Y., Semnanian S. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats. Neuroscience Letters 2012, 515:174-176.
15. Baker G.B., Bornstein R.A., Douglass A.B., Carroll A., King G. Urinary excretion of metabolites of norepinephrine in Tourette's syndrome. Molecular and Chemical Neuropathology 1990, 13:225-232.
16. Barbeau A., Duvoisin R.C., Gerstenbrand F., Lakke J.P., Marsden C.D., Stern G. Classification of extrapyramidal disorders. Proposal for an international classification and glossary of terms. Journal of Neurological Science 1981, 51:311-327.
17. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38:1083-1152.
18. Beaulieu J.M., Gainetdinov R.R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacological Reviews 2011, 63:182-217.
19. Bedard P., Pycock C.J. " Wet-dog" shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity. Neuropharmacology 1977, 16:663-670.
20. Bennett B.D., Bolam J.P. Synaptic input and output of parvalbumin-immunoreactive neurons in the neostriatum of the rat. Neuroscience 1994, 62:707-719.
21. Berridge C.W. Noradrenergic modulation of arousal. Brain Research Reviews 2008, 58:1-17.
22. Bevan M.D., Booth P.A., Eaton S.A., Bolam J.P. Selective innervation of neostriatal interneurons by a subclass of neuron in the globus pallidus of the rat. Journal of Neuroscience 1998, 18:9438-9452.
23. Blin O., Masson G., Azulay J.P., Fondarai J., Serratrice G. Apomorphine-induced blinking and yawning in healthy volunteers. British Journal of Clinical Pharmacology 1990, 30:769-773.
24. Bloch M.H., Leckman J.F. Clinical course of Tourette syndrome. Journal of Psychosomatic Research 2009, 67:497-501.
25. Bloch M.H., Leckman J.F., Zhu H., Peterson B.S. Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology 2005, 65:1253-1258.
26. Bloch M.H., Peterson B.S., Scahill L., Otka J., Katsovich L., Zhang H., Leckman J.F. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Archives of Pediatrics & Adolescent Medicine 2006, 160:65-69.
27. Bolam J.P., Hanley J.J., Booth P.A., Bevan M.D. Synaptic organisation of the basal ganglia. Journal of Anatomy 2000, 196(Pt 4):527-542.
28. Bolam J.P., Wainer B.H., Smith A.D. Characterization of cholinergic neurons in the rat neostriatum. A combination of choline acetyltransferase immunocytochemistry, Golgi-impregnation and electron microscopy. Neuroscience 1984, 12:711-718.
29. Bornstein R.A., Baker G.B. Urinary amines in Tourette's syndrome patients with and without phenylethylamine abnormality. Psychiatry Research 1990, 31:279-286.
30. Bornstein R.A., Baker G.B. Urinary indoleamines in Tourette syndrome patients with obsessive-compulsive characteristics. Psychiatry Research 1992, 41:267-274.
31. Bornstein R.A., Baker G.B. Urinary amines in adults with Tourette's syndrome. Psychiatry Research 1992, 43:277-285.
32. Boyden E.S., Zhang F., Bamberg E., Nagel G., Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. Nature Neuroscience 2005, 8.
33. Braun A.R., Randolph C., Stoetter B., Mohr E., Cox C., Vladar K., Sexton R., Carson R.E., Herscovitch P., Chase T.N. The functional neuroanatomy of Tourette's syndrome: an FDG-PET Study. II: Relationships between regional cerebral metabolism and associated behavioral and cognitive features of the illness. Neuropsychopharmacology 1995, 13:151-168.
34. Briand L.A., Gritton H., Howe W.M., Young D.A., Sarter M. Modulators in concert for cognition: modulator interactions in the prefrontal cortex. Progress in Neurobiology 2007, 83:69-91.
35. Bronfeld M., Bar-Gad I. Tic Disorders: What Happens in the Basal Ganglia?. Neuroscientist 2012.
36. Bronfeld M., Belelovsky K., Bar-Gad I. Spatial and temporal properties of tic-related neuronal activity in the cortico-Basal Ganglia loop. Journal of Neuroscience 2011, 31:8713-8721.
37. Bronfeld M., Belelovsky K., Erez Y., Bugaysen J., Korngreen A., Bar-Gad I. Bicuculline induced chorea manifests in focal rather than globalized abnormalities in the activation of the external and internal globus pallidus. Journal of Neurophysiology 2010, 104:3261-3275.
38. Buhot M.C. Serotonin receptors in cognitive behaviors. Current Opinion in Neurobiology 1997, 7:243-254.
39. Burke K., Lombroso P.J. Animal models of Tourette syndrome. Animal Models of Movement Disorders 2005, 441-448. Elsevier Academic Press. M. LeDoux (Ed.).
40. Butcher L.L., Woolf N.J. Cholinergic and serotonergic systems in the brain and spinal cord: anatomic organization, role in intercellular communication processes, and interactive mechanisms. Progress in Brain Research 1982, 55:1-40.
41. Carasso B.S., Bakshi V.P., Geyer M.A. Disruption in prepulse inhibition after alpha-1 adrenoceptor stimulation in rats. Neuropharmacology 1998, 37:401-404.
42. Castellanos F.X., Fine E.J., Kaysen D., Marsh W.L., Rapoport J.L., Hallett M. Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results. Biological Psychiatry 1996, 39:33-41.
43. Charara A., Parent A. Brainstem dopaminergic, cholinergic and serotoninergic afferents to the pallidum in the squirrel monkey. Brain Research 1994, 640:155-170.
44. Cheon K.A., Ryu Y.H., Namkoong K., Kim C.H., Kim J.J., Lee J.D. Dopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drug-naive children with Tourette's disorder. Psychiatry Research 2004, 130:85-95.
45. Comings D.E. Blood serotonin and tryptophan in Tourette syndrome. American Journal of Medical Genetics 1990, 36:418-430.
46. Conelea C.A., Woods D.W. The influence of contextual factors on tic expression in Tourette's syndrome: a review. Journal of Psychosomatic Research 2008, 65:487-496.
47. Corne S.J., Pickering R.W., Warner B.T. A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. British Journal of Pharmacology and Chemotherapy 1963, 20:106-120.
48. Crossman A.R., Mitchell I.J., Sambrook M.A., Jackson A. Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. The site of drug action and a hypothesis for the neural mechanisms of chorea. Brain 1988, 111(Pt 5):1211-1233.
49. Crossman A.R., Sambrook M.A., Jackson A. Experimental hemichorea/hemiballismus in the monkey. Studies on the intracerebral site of action in a drug-induced dyskinesia. Brain 1984, 107(Pt 2):579-596.
50. Dahlstroem A., Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiologica Scandinavica, Supplementum 1964, (Suppl. 55).
51. Dantzer R. Stress, Stereotypies and Welfare. Behavioural Processes 1991, 25:95-102.
52. Dayan L., Finberg J.P. L-DOPA increases noradrenaline turnover in central and peripheral nervous systems. Neuropharmacology 2003, 45:524-533.
53. de la Tourette G. Etude sur une Affection Nerveuse Caracterisee par de l'Incoordination Motrice Accompagnee d'Echolalie et de Coprolalie (jumping, lateh. myriachit). Archives de Neurologie 1885, 9:19-42.
54. Del R.J., Fuentes J.A. Further studies on the antagonism of stereotyped behaviour induced by amphetamine. European Journal of Pharmacology 1969, 8:73-78.
55. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends in Neuroscience 1990, 13:281-285.
56. DeLong M.R., Crutcher M.D., Georgopoulos A.P. Primate globus pallidus and subthalamic nucleus: functional organization. Journal of Neurophysiology 1985, 53:530-543.
57. Di Chiara G., Morelli M., Consolo S. Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends in Neuroscience 1994, 17:228-233.
58. Di Matteo V., Di Giovanni G., Pierucci M., Esposito E. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies. Progress in Brain Research 2008, 172:7-44.
59. Dickinson S.L., Andrews C.D., Curzon G. The effects of lesions produced by 5,7-dihydroxytryptamine on 5-hydroxytryptamine-mediated behaviour induced by amphetamine in large doses in the rat. Neuropharmacology 1984, 23:423-429.
60. Diederich N.J., Kalteis K., Stamenkovic M., Pieri V., Alesch F. Efficient internal pallidal stimulation in Gilles de la Tourette syndrome: a case report. Movement Disorders 2005, 20:1496-1499.
61. Drago A., Crisafulli C., Sidoti A., Serretti A. The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes. Progress in Neurobiology 2011, 94:418-460.
62. Dursun S.M., Handley S.L. Similarities in the pharmacology of spontaneous and DOI-induced head-shakes suggest 5HT2A receptors are active under physiological conditions. Psychopharmacology (Berlin) 1996, 128:198-205.
63. Egashira N., Mishima K., Uchida T., Hasebe N., Nagai H., Mizuki A., Iwasaki K., Ishii H., Nishimura R., Shoyama Y., Fujiwara M. Anandamide inhibits the DOI-induced head-twitch response in mice. Psychopharmacology (Berlin) 2004, 171:382-389.
64. Eilam D., Zor R., Szechtman H., Hermesh H. Rituals, stereotypy and compulsive behavior in animals and humans. Neuroscience & Biobehavioral Review 2006, 30:456-471.
65. English D.F., Ibanez-Sandoval O., Stark E., Tecuapetla F., Buzsaki G., Deisseroth K., Tepper J.M., Koos T. GABAergic circuits mediate the reinforcement-related signals of striatal cholinergic interneurons. Nature Neuroscience 2012, 15:123-130.
66. Fahim C., Yoon U., Sandor P., Frey K., Evans A.C. Thinning of the motor-cingulate-insular cortices in siblings concordant for Tourette syndrome. Brain Topography 2009, 22:176-184.
67. Farid M., Martinez Z.A., Geyer M.A., Swerdlow N.R. Regulation of sensorimotor gating of the startle reflex by serotonin 2A receptors. Ontogeny and strain differences. Neuropsychopharmacology 2000, 23:623-632.
68. Fog R. Stereotyped and non-stereotyped behaviour in rats induced by various stimulant drugs. Psychopharmacologia 1969, 14:299-304.
69. Foote S.L., Bloom F.E., ston-Jones G. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiological Reviews 1983, 63:844-914.
70. Francois C., Grabli D., McCairn K., Jan C., Karachi C., Hirsch E.C., Feger J., Tremblay L. Behavioural disorders induced by external globus pallidus dysfunction in primates II. Anatomical study. Brain 2004, 127:2055-2070.
71. Freedman D.X., Giarman N.J. Apomorphine test for tranquilizing drugs: effect of dibenamine. Science 1956, 124:264-265.
72. Freeman R.D., Fast D.K., Burd L., Kerbeshian J., Robertson M.M., Sandor P. An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Developmental Medcine & Child Neurology 2000, 42:436-447.
73. Fujimoto S., Sasa M., Takaori S. Inhibition from locus coeruleus of caudate neurons activated by nigral stimulation. Brain Research Bulletin 1981, 6:267-274.
74. Gadow K.D., Sverd J., Sprafkin J., Nolan E.E., Grossman S. Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Archives of General Psychiatry 1999, 56:330-336.
75. Gaynor C.M., Handley S.L. Effects of nicotine on head-shakes and tryptophan metabolites. Psychopharmacology (Berlin) 2001, 153:327-333.
76. George M.S., Robertson M.M., Costa D.C., Ell P.J., Trimble M.R., Pilowsky L., Verhoeff N.P. Dopamine receptor availability in Tourette's syndrome. Psychiatry Research 1994, 55:193-203.
77. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990, 250:1429-1432.
78. Gerfen C.R., Wilson C.J. The basal ganglia. Handbook of Chemical Neuroanatomy, Vol 12: Integrated Systems of the CNS, Part III 1996, 371-468. Elsevier Science. L.W. Swanson, A. Bjorklund, T. Hokfelt (Eds.).
79. Geyer M.A. The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps?. Neurotoxicity Research 2006, 10:211-220.
80. Gittis A.H., Leventhal D.K., Fensterheim B.A., Pettibone J.R., Berke J.D., Kreitzer A.C. Selective inhibition of striatal fast-spiking interneurons causes dyskinesias. Journal of Neuroscience 2011, 31:15727-15731.
81. Grabli D., McCairn K., Hirsch E.C., Agid Y., Feger J., Francois C., Tremblay L. Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study. Brain 2004, 127:2039-2054.
82. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 1991, 41:1-24.
83. Graham F.K. Presidential Address, 1974. The more or less startling effects of weak prestimulation. Psychophysiology 1975, 12:238-248.
84. Graybiel A.M., Aosaki T., Flaherty A.W., Kimura M. The basal ganglia and adaptive motor control. Science 1994, 265:1826-1831.
85. Haber S.N., Fudge J.L., McFarland N.R. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. Journal of Neuroscience 2000, 20:2369-2382.
86. Haber S.N., Gdowski M.J. The Basal Ganglia. The Human Nervous System 2004, second ed.
87. Hampson M., Tokoglu F., King R.A., Constable R.T., Leckman J.F. Brain areas coactivating with motor cortex during chronic motor tics and intentional movements. Biological Psychiatry 2009, 65:594-599.
88. Handley S.L., Brown J. Effects on the 5-hydroxytryptamine-induced head-twitch of drugs with selective actions on alpha1 and alpha2-adrenoceptors. Neuropharmacology 1982, 21:507-510.
89. Handley S.L., Dursun S.M. Serotonin and Tourette's syndrome: movements such as head-shakes and wet-dog shakes may model human tics. Serotonin, CNS Receptors and Brain Function 1992, 235-253. Pergamon Press, Oxford, U.K. P.B. Bradley, S.L. Handley, S.J. Cooper, B.J. Key, N.M. Barnes, J.H. Coote (Eds.).
90. Handley S.L., Singh L. Modulation of 5-hydroxytryptamine-induced head-twitch response by drugs acting at GABA and related receptors. British Journal of Pharmacology 1985, 86:297-303.
91. Hariz M.I., Robertson M.M. Gilles de la Tourette syndrome and deep brain stimulation. European Journal of Neuroscience 2010, 32:1128-1134.
92. Hartman B.K. Immunofluorescence of dopamine- -hydroxylase. Application of improved methodology to the localization of the peripheral and central noradrenergic nervous system. Journal of Histochemistry & Cytochemistry 1973, 21:312-332.
93. Haugbol S., Pinborg L.H., Regeur L., Hansen E.S., Bolwig T.G., Nielsen F.A., Svarer C., Skovgaard L.T., Knudsen G.M. Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome. International Journal of Neuropsychopharmacology 2007, 10:245-252.
94. Hedreen J.C., DeLong M.R. Organization of striatopallidal, striatonigral, and nigrostriatal projections in the macaque. Journal of Comparative Neurology 1991, 304:569-595.
95. Heinz A., Knable M.B., Wolf S.S., Jones D.W., Gorey J.G., Hyde T.M., Weinberger D.R. Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity. Neurology 1998, 51:1069-1074.
96. Hoffman D.C., Donovan H. D1 and D2 dopamine receptor antagonists reverse prepulse inhibition deficits in an animal model of schizophrenia. Psychopharmacology (Berlin) 1994, 115:447-453.
97. Hoover J.E., Strick P.L. Multiple output channels in the basal ganglia. Science 1993, 259:819-821.
98. Houeto J.L., Karachi C., Mallet L., Pillon B., Yelnik J., Mesnage V., Welter M.L., Navarro S., Pelissolo A., Damier P., Pidoux B., Dormont D., Cornu P., Agid Y. Tourette's syndrome and deep brain stimulation. Journal of Neurology, Neurosurgery & Psychiatry 2005, 76:992-995.
99. Hutchison K.E., Swift R. Effect of d-amphetamine on prepulse inhibition of the startle reflex in humans. Psychopharmacology (Berlin) 1999, 143:394-400.
100. Ibanez-Sandoval O., Tecuapetla F., Unal B., Shah F., Koos T., Tepper J.M. A novel functionally distinct subtype of striatal neuropeptide Y interneuron. Journal of Neuroscience 2011, 31:16757-16769.
101. Ibanez-Sandoval O., Tecuapetla F., Unal B., Shah F., Koos T., Tepper J.M. Electrophysiological and morphological characteristics and synaptic connectivity of tyrosine hydroxylase-expressing neurons in adult mouse striatum. Journal of Neuroscience 2010, 30:6999-7016.
102. Ikeda H., Kotani A., Koshikawa N., Cools A.R. Differential role of GABAA and GABAB receptors in two distinct output stations of the rat striatum: studies on the substantia nigra pars reticulata and the globus pallidus. Neuroscience 2010, 167:31-39.
103. Inase M., Tanji J. Thalamic distribution of projection neurons to the primary motor cortex relative to afferent terminal fields from the globus pallidus in the macaque monkey. Journal of Comparative Neurology 1995, 353:415-426.
104. Ison J.R., McAdam D.W., Hammond G.R. Latency and amplitude changes in the acoustic startle reflex of the rat produced by variation in auditory prestimulation. Physiology & Behavior 1973, 10:1035-1039.
105. Jaeger D., Kita H., Wilson C.J. Surround inhibition among projection neurons is weak or nonexistent in the rat neostriatum. Journal of Neurophysiology 1994, 72:2555-2558.
106. Jinnah H.A., Hess E.J. Assessment of movement disorders in rodents. Animal Models of Movement Disorders 2005, 55-72. Elsevier Academic Press. M. LeDoux (Ed.).
107. Joel D. Current animal models of obsessive compulsive disorder: a critical review. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2006, 30:374-388.
108. Joel D., Weiner I. The organization of the basal ganglia-thalamocortical circuits: open interconnected rather than closed segregated. Neuroscience 1994, 63:363-379.
109. Johansson C., Jackson D.M., Zhang J., Svensson L. Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats. Pharmacology Biochemistry & Behavior 1995, 52:649-654.
110. Kalanithi P.S., Zheng W., Kataoka Y., DiFiglia M., Grantz H., Saper C.B., Schwartz M.L., Leckman J.F., Vaccarino F.M. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proceedings of National Academy of Science of the United States of America 2005, 102:13307-13312.
111. Kataoka Y., Kalanithi P.S., Grantz H., Schwartz M.L., Saper C., Leckman J.F., Vaccarino F.M. Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. Journal of Comparative Neurology 2010, 518:277-291.
112. Kawaguchi Y., Wilson C.J., Augood S.J., Emson P.C. Striatal interneurones: chemical, physiological and morphological characterization. Trends in Neuroscience 1995, 18:527-535.
113. Kehne J.H., Padich R.A., McCloskey T.C., Taylor V.L., Schmidt C.J. 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats. Psychopharmacology (Berlin) 1996, 124:95-106.
114. Kelley A.E., Lang C.G., Gauthier A.M. Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum. Psychopharmacology (Berlin) 1988, 95:556-559.
115. Kennett G.A., Curzon G. Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia. British Journal of Pharmacology 1991, 103:2016-2020.
116. Kimura M., Rajkowski J., Evarts E. Tonically discharging putamen neurons exhibit set-dependent responses. Proceedings of National Academy of Science of the United States ofAmerica 1984, 81:4998-5001.
117. Kita H., Chiken S., Tachibana Y., Nambu A. Serotonin modulates pallidal neuronal activity in the awake monkey. Journal of Neuroscience 2007, 27:75-83.
118. Kita H., Kitai S.T. The morphology of globus pallidus projection neurons in the rat: an intracellular staining study. Brain Research 1994, 636:308-319.
119. Kita H., Kosaka T., Heizmann C.W. Parvalbumin-immunoreactive neurons in the rat neostriatum: a light and electron microscopic study. Brain Research 1990, 536:1-15.
120. Kodsi M.H., Swerdlow N.R. Prepulse inhibition in the rat is regulated by ventral and caudodorsal striato-pallidal circuitry. Behavioral Neuroscience 1995, 109:912-928.
121. Kokkinidis L., Anisman H. Amphetamine psychosis and schizophrenia: a dual model. Neuroscience & Biobehavioral Reviews 1981, 5:449-461.
122. Koos T., Tepper J.M. Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nature Neuroscience 1999, 2:467-472.
123. Koos T., Tepper J.M., Wilson C.J. Comparison of IPSCs evoked by spiny and fast-spiking neurons in the neostriatum. Journal of Neuroscience 2004, 24:7916-7922.
124. Kwak C., Dat V.K., Jankovic J. Premonitory sensory phenomenon in Tourette's syndrome. Movement Disorders 2003, 18:1530-1533.
125. Lahdesmaki J., Sallinen J., MacDonald E., Scheinin M. Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines. Neuropsychopharmacology 2004, 29:1282-1293.
126. Lavoie B., Parent A. Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey. Journal of Comparative Neurology 1990, 299:1-16.
127. Lavoie B., Parent A. Pedunculopontine nucleus in the squirrel monkey: projections to the basal ganglia as revealed by anterograde tract-tracing methods. Journal of Comparative Neurology 1994, 344:210-231.
128. Leckman J.F., Goodman W.K., Anderson G.M., Riddle M.A., Chappell P.B., Swiggan-Hardin M.T., McDougle C.J., Scahill L.D., Ort S.I., Pauls D.L., Cohen D.J., Price L.H. Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology 1995, 12:73-86.
129. Leckman J.F., Hardin M.T., Riddle M.A., Stevenson J., Ort S.I., Cohen D.J. Clonidine treatment of Gilles de la Tourette's syndrome. Archives of General Psychiatry 1991, 48:324-328.
130. Leckman J.F., Walker D.E., Cohen D.J. Premonitory urges in Tourette's syndrome. American Journal of Psychiatry 1993, 150:98-102.
131. Leckman J.F., Zhang H., Vitale A., Lahnin F., Lynch K., Bondi C., Kim Y.S., Peterson B.S. Course of tic severity in Tourette syndrome: the first two decades. Pediatrics 1998, 102:14-19.
132. LeDoux M. Animal models and the science of movement disorders. Animal Models of Movement Disorders 2005, 13-32. Elsevier Academic Press. M. LeDoux (Ed.).
133. Lerner A., Bagic A., Simmons J.M., Mari Z., Bonne O., Xu B., Kazuba D., Herscovitch P., Carson R.E., Murphy D.L., Drevets W.C., Hallett M. Widespread abnormality of the gamma-aminobutyric acid-ergic system in Tourette syndrome. Brain 2012.
134. Leysen J.E., Janssen P.M., Schotte A., Luyten W.H., Megens A.A. Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors. Psychopharmacology (Berlin) 1993, 112:S40-S54.
135. Lind N.M., Arnfred S.M., Hemmingsen R.P., Hansen A.K. Prepulse inhibition of the acoustic startle reflex in pigs and its disruption by d-amphetamine. Behavioral Brain Research 2004, 155:217-222.
136. Lucki I. The spectrum of behaviors influenced by serotonin. Biological Psychiatry 1998, 44:151-162.
137. Lutjens G., Krauss J.K., Schwabe K. Lesions of the entopeduncular nucleus in rats prevent apomorphine-induced deficient sensorimotor gating. Behavioral Brain Research 2011, 220:281-287.
138. Mansbach R.S., Geyer M.A., Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berlin) 1988, 94:507-514.
139. Marsden C.D., Meldrum B.S., Pycock C., Tarsy D. Focal myoclonus produced by injection of picrotoxin into the caudate nucleus of the rat. Journal of Physiology 1975, 246:96P.
140. Mason G.J. Stereotypies - A Critical-Review. Animal Behaviour 1991, 41:1015-1037.
141. Matthysse S. Animal models in psychiatric research. Progress in Brain Research 1986, 65:259-270.
142. McCairn K.W., Bronfeld M., Belelovsky K., Bar-Gad I. The neurophysiological correlates of motor tics following focal striatal disinhibition. Brain 2009, 132:2125-2138.
143. McDougle C.J., Goodman W.K., Leckman J.F., Barr L.C., Heninger G.R., Price L.H. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. Journal of Clinical Psychopharmacology 1993, 13:354-358.
144. McFarland N.R., Haber S.N. Convergent inputs from thalamic motor nuclei and frontal cortical areas to the dorsal striatum in the primate. Journal of Neuroscience 2000, 20:3798-3813.
145. McKenzie G.M., Gordon R.J., Viik K. Some biochemical and behavioural correlates of a possible animal model of human hyperkinetic syndromes. Brain Research 1972, 47:439-456.
146. McKenzie G.M., Viik K. Chemically induced chorieform activity: antagonism by GABA and EEG patterns. Experimental Neurology 1975, 46:229-243.
147. Meltzer H.Y., Nash J.F. Effects of antipsychotic drugs on serotonin receptors. Pharmacological Reviews 1991, 43:587-604.
148. Mesulam M.M., Mash D., Hersh L., Bothwell M., Geula C. Cholinergic innervation of the human striatum, globus pallidus, subthalamic nucleus, substantia nigra, and red nucleus. Journal of Comparative Neurology 1992, 323:252-268.
149. Middleton F.A., Strick P.L. Anatomical evidence for cerebellar and basal ganglia involvement in higher cognitive function. Science 1994, 266:458-461.
150. Miller J.J., Richardson T.L., Fibiger H.C., McLennan H. Anatomical and electrophysiological identification of a projection from the mesencephalic raphe to the caudate-putamen in the rat. Brain Research 1975, 97:133-136.
151. Mink J.W. The Basal Ganglia and involuntary movements: impaired inhibition of competing motor patterns. Archives of Neurology 2003, 60:1365-1368.
152. Mink J.W. The basal ganglia: focused selection and inhibition of competing motor programs. Progress in Neurobiology 1996, 50:381-425.
153. Monti J.M., Jantos H. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. Progress in Brain Research 2008, 172:625-646.
154. Morgane P.J., Jacobs M.S. Raphe projections to the locus coeruleus in the rat. Brain Research Bulletin 1979, 4:519-534.
155. Muller-Vahl K.R., Meyer G.J., Knapp W.H., Emrich H.M., Gielow P., Brucke T., Berding G. Serotonin transporter binding in Tourette Syndrome. Neuroscience Letters 2005, 385:120-125.
156. Muramatsu S., Yoshida M., Nakamura S. Electrophysiological study of dyskinesia produced by microinjection of picrotoxin into the striatum of the rat. Neuroscience in Research 1990, 7:369-380.
157. Nakamura S., Muramatsu S., Yoshida M. Role of the basal ganglia in manifestation of rhythmical jaw movement in rats. Brain Research 1990, 535:335-338.
158. Nambu A., Tokuno H., Hamada I., Kita H., Imanishi M., Akazawa T., Ikeuchi Y., Hasegawa N. Excitatory cortical inputs to pallidal neurons via the subthalamic nucleus in the monkey. Journal of Neurophysiology 2000, 84:289-300.
159. Nanopoulos D., Belin M.F., Maitre M., Vincendon G., Pujol J.F. Immunocytochemical evidence for the existence of GABAergic neurons in the nucleus raphe dorsalis. Possible existence of neurons containing serotonin and GABA. Brain Research 1982, 232:375-389.
160. Nevet A., Morris G., Saban G., Fainstein N., Bergman H. Discharge rate of substantia nigra pars reticulata neurons is reduced in non-parkinsonian monkeys with apomorphine-induced orofacial dyskinesia. Journal of Neurophysiology 2004, 92:1973-1981.
161. Olpe H.R., Koella W.P. The response of striatal cells upon stimulation of the dorsal and median raphe nuclei. Brain Research 1977, 122:357-360.
162. Overstreet L.S., Jones M.V., Westbrook G.L. Slow desensitization regulates the availability of synaptic GABA(A) receptors. Journal of Neuroscience 2000, 20:7914-7921.
163. Overstreet L.S., Westbrook G.L. Paradoxical reduction of synaptic inhibition by vigabatrin. Journal of Neurophysiology 2001, 86:596-603.
164. Padich R.A., McCloskey T.C., Kehne J.H. 5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats. Psychopharmacology (Berlin) 1996, 124:107-116.
165. Parent A., Cote P.Y., Lavoie B. Chemical anatomy of primate basal ganglia. Progress in Neurobiology 1995, 46:131-197.
166. Parent A., Descarries L., Beaudet A. Organization of ascending serotonin systems in the adult rat brain. A radioautographic study after intraventricular administration of [3H]5-hydroxytryptamine. Neuroscience 1981, 6:115-138.
167. Parent A., Hazrati L.N. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Research Brain Research Reviews 1995, 20:91-127.
168. Parent A., Mackey A., De Bellefeuille L. The subcortical afferents to caudate nucleus and putamen in primate: a fluorescence retrograde double labeling study. Neuroscience 1983, 10:1137-1150.
169. Patel S., Slater P. Analysis of the brain regions involved in myoclonus produced by intracerebral picrotoxin. Neuroscience 1987, 20:687-693.
170. Peterson B.S., Skudlarski P., Anderson A.W., Zhang H., Gatenby J.C., Lacadie C.M., Leckman J.F., Gore J.C. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. Archives of General Psychiatry 1998, 55:326-333.
171. Peterson B.S., Thomas P., Kane M.J., Scahill L., Zhang H., Bronen R., King R.A., Leckman J.F., Staib L. Basal Ganglia volumes in patients with Gilles de la Tourette syndrome. Archives of General Psychiatry 2003, 60:415-424.
172. Porrino L.J., Lucignani G., Dow-Edwards D., Sokoloff L. Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats. Brain Research 1984, 307:311-320.
173. Posch D.K., Schwabe K., Krauss J.K., Lutjens G. Deep brain stimulation of the entopeduncular nucleus in rats prevents apomorphine-induced deficient sensorimotor gating. Behavioral Brain Research 2012, 232:130-136.
174. Ralph R.J., Paulus M.P., Geyer M.A. Strain-specific effects of amphetamine on prepulse inhibition and patterns of locomotor behavior in mice. Journal of Pharmacology and Experimental Therapeutics 2001, 298:148-155.
175. Randrup A., Munkvad I. Special antagonism of amphetamine-induced abnormal behaviour. Inhibition of stereotyped activity with increase of some normal activities. Psychopharmacologia 1965, 7:416-422.
176. Randrup A., Munkvad I. Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia 1967, 11:300-310.
177. Randrup A., Munkvad I., Udsen P. Adrenergic mechanisms and amphetamine induced abnormal behaviour. Acta Pharmacologica et Toxicologica (Copenh) 1963, 20:145-157.
178. Richerson G.B., Wu Y. Dynamic equilibrium of neurotransmitter transporters: not just for reuptake anymore. Journal of Neurophysiology 2003, 90:1363-1374.
179. Ridley R.M. The psychology of perserverative and stereotyped behaviour. Progress in Neurobiology 1994, 44:221-231.
180. Ridley R.M., Baker H.F., Owen F., Cross A.J., Crow T.J. Behavioural and biochemical effects of chronic amphetamine treatment in the vervet monkey. Psychopharmacology (Berlin) 1982, 78:245-251.
181. Rigdon G.C. Differential effects of apomorphine on prepulse inhibition of acoustic startle reflex in two rat strains. Psychopharmacology (Berlin) 1990, 102:419-421.
182. Russell R.L., Pihl R.O. The effect of dose, novelty, and exploration on amphetamine-produced stereotyped behavior. Psychopharmacology (Berlin) 1978, 60:93-100.
183. Sacco K.A., Bannon K.L., George T.P. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. Journal of Psychopharmacology 2004, 18:457-474.
184. Sallinen J., Haapalinna A., Viitamaa T., Kobilka B.K., Scheinin M. D-amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the alpha2C-adrenergic receptor subtype. Neuroscience 1998, 86:959-965.
185. Sallinen J., Haapalinna A., Viitamaa T., Kobilka B.K., Scheinin M. Adrenergic alpha2C-receptors modulate the acoustic startle reflex, prepulse inhibition, and aggression in mice. Journal of Neuroscience 1998, 18:3035-3042.
186. Sara S.J. The locus coeruleus and noradrenergic modulation of cognition. Nature Reviews Neuroscience 2009, 10:211-223.
187. Scahill L., Erenberg G., Berlin C.M., Budman C., Coffey B.J., Jankovic J., Kiessling L., King R.A., Kurlan R., Lang A., Mink J., Murphy T., Zinner S., Walkup J. Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx 2006, 3:192-206.
188. Schultz W. Multiple dopamine functions at different time courses. Annual Review of Neuroscience 2007, 30:259-288.
189. Schultz W. Dopamine neurons and their role in reward mechanisms. Current Opinion in Neurobiology 1997, 7:191-197.
190. Schultz W., Dayan P., Montague P.R. A neural substrate of prediction and reward. Science 1997, 275:1593-1599.
191. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1987, 1:133-152.
192. Shapiro A.K., Shapiro E. Treatment of Gilles de la Tourette's Syndrome with haloperidol. British Journal of Psychiatry 1968, 114:345-350.
193. Shapiro E., Shapiro A.K., Fulop G., Hubbard M., Mandeli J., Nordlie J., Phillips R.A. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Archives of General Psychiatry 1989, 46:722-730.
194. Shilling P.D., Melendez G., Priebe K., Richelson E., Feifel D. Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an alpha1 agonist. Psychopharmacology (Berlin) 2004, 175:353-359.
195. Shin E.J., Jeong J.H., Chung Y.H., Kim T.W., Shin C.Y., Kim W.K., Ko K.H., Kim H.C. Decrease in the kainate-induced wet dog shake behavior in genetically epilepsy-prone rats: possible involvement of an impaired synaptic transmission to the 5-HT(2A) receptor. Journal of Pharmacological Sciences 2009, 110:401-404.
196. Sibley D.R., Monsma F.J. Molecular biology of dopamine receptors. Trends in Pharmacological Sciences 1992, 13:61-69.
197. Singer H.S. Treatment of tics and tourette syndrome. Current Treatment Options in Neurology 2010, 12:539-561.
198. Singer H.S., Butler I.J., Tune L.E., Seifert W.E., Coyle J.T. Dopaminergic dsyfunction in Tourette syndrome. Annals of Neurology 1982, 12:361-366.
199. Singer H.S., Hahn I.H., Krowiak E., Nelson E., Moran T. Tourette's syndrome: a neurochemical analysis of postmortem cortical brain tissue. Annals of Neurology 1990, 27:443-446.
200. Singer H.S., Rabins P., Tune L.E., Coyle J.T. Serum haloperidol levels in Gilles de la Tourette syndrome. Biological Psychiatry 1981, 16:79-84.
201. Singer H.S., Szymanski S., Giuliano J., Yokoi F., Dogan A.S., Brasic J.R., Zhou Y., Grace A.A., Wong D.F. Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. American Journal of Psychiatry 2002, 159:1329-1336.
202. Sipes T.A., Geyer M.A. Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology 1994, 33:441-448.
203. Sipes T.E., Geyer M.A. DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum. Brain Research 1997, 761:97-104.
204. Sirvio J., Riekkinen P., Jakala P., Riekkinen P.J. Experimental studies on the role of serotonin in cognition. Progress in Neurobiology 1994, 43:363-379.
205. Slater P., Dickinson S.L. Role of acetylcholine and dopamine in myoclonus induced by intrastriatal picrotoxin. Neuroscience Letters 1982, 28:253-257.
206. Solanto M.V. Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behavioural Brain Research 2002, 130:65-71.
207. Southwick S.M., Bremner J.D., Rasmusson A., Morgan C.A., Arnsten A., Charney D.S. Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biological Psychiatry 1999, 46:1192-1204.
208. Sowell E.R., Kan E., Yoshii J., Thompson P.M., Bansal R., Xu D., Toga A.W., Peterson B.S. Thinning of sensorimotor cortices in children with Tourette syndrome. Nature Neuroscience 2008, 11:637-639.
209. Stamenkovic M., Schindler S.D., Asenbaum S., Neumeister A., Willeit M., Willinger U., de Z.M., Riederer F., Aschauer H.N., Kasper S. No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette's disorder patients: a [(123)I]-beta-CIT SPECt-study. European Neuropsychopharmacology 2001, 11:69-74.
210. Steeves T.D., Fox S., H Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome. Progress in Brain Research 2008, 172:495-513.
211. Steeves T.D., Ko J.H., Kideckel D.M., Rusjan P., Houle S., Sandor P., Lang A.E., Strafella A.P. Extrastriatal dopaminergic dysfunction in tourette syndrome. Annals of Neurology 2010, 67:170-181.
212. Sullivan G.M., Coplan J.D., Kent J.M., Gorman J.M. The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias. Biological Psychiatry 1999, 46:1205-1218.
213. Swerdlow N.R., Bongiovanni M.J., Tochen L., Shoemaker J.M. Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette Syndrome. Psychopharmacology (Berlin) 2006, 186:246-254.
214. Swerdlow N.R., Braff D.L., Geyer M.A. GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats. Brain Research 1990, 532:146-150.
215. Swerdlow N.R., Braff D.L., Geyer M.A. Cross-species studies of sensorimotor gating of the startle reflex. Annals of the New York Academy of Sciences 1999, 877:202-216.
216. Swerdlow N.R., Karban B., Ploum Y., Sharp R., Geyer M.A., Eastvold A. Tactile prepuff inhibition of startle in children with Tourette's syndrome: in search of an " fMRI-friendly" startle paradigm. Biological Psychiatry 2001, 50:578-585.
217. Swerdlow N.R., Platten A., Shoemaker J., Pitcher L., Auerbach P. Effects of pergolide on sensorimotor gating of the startle reflex in rats. Psychopharmacology (Berlin) 2001, 158:230-240.
218. Swerdlow N.R., Shoemaker J.M., Bongiovanni M.J., Neary A.C., Tochen L.S., Saint Marie R.L. Strain differences in the disruption of prepulse inhibition of startle after systemic and intra-accumbens amphetamine administration. Pharmacology Biochemistry & Behavior 2007, 87:1-10.
219. Swerdlow N.R., Shoemaker J.M., Platten A., Pitcher L., Goins J., Crain S. Heritable differences in the effects of amphetamine but not DOI on startle gating in albino and hooded outbred rat strains. Pharmacology Biochemistry & Behavior 2003, 75:191-197.
220. Swerdlow N.R., Sutherland A.N. Using animal models to develop therapeutics for Tourette Syndrome. Pharmacology & Therapeutics 2005, 108:281-293.
221. Szabo B., Fritz T., Wedzony K. Effects of imidazoline antihypertensive drugs on sympathetic tone and noradrenaline release in the prefrontal cortex. British Journal of Pharmacology 2001, 134:295-304.
222. Tarsy D., Pycock C.J., Meldrum B.S., Marsden C.D. Focal contralateral myoclonus produced by inhibition of GABA action in the caudate nucleus of rats. Brain 1978, 101:143-162.
223. Tepper J.M., Bolam J.P. Functional diversity and specificity of neostriatal interneurons. Current Opinion in Neurobiology 2004, 14:685-692.
224. Tizabi Y., Russell L.T., Johnson M., Darmani N.A. Nicotine attenuates DOI-induced head-twitch response in mice: implications for Tourette syndrome. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2001, 25:1445-1457.
225. Tokuno H., Kimura M., Tanji J. Pallidal inputs to thalamocortical neurons projecting to the supplementary motor area: an anterograde and retrograde double labeling study in the macaque monkey. Experimental Brain Research 1992, 90:635-638.
226. Tse S.Y., Wei E.T. Inhibition of the shake response in rats by adenosine and 2-chloroadenosine. Psychopharmacology (Berlin) 1986, 90:322-326.
227. Tunstall M.J., Oorschot D.E., Kean A., Wickens J.R. Inhibitory interactions between spiny projection neurons in the rat striatum. Journal of Neurophysiology 2002, 88:1263-1269.
228. Turjanski N., Sawle G.V., Playford E.D., Weeks R., Lammerstma A.A., Lees A.J., Brooks D.J. Pet Studies of the Presynaptic and Postsynaptic Dopaminergic System in Tourettes-Syndrome. Journal of Neurology Neurosurgery and Psychiatry 1994, 57:688-692.
229. Unsalan N., Saglam E., Kayir H., Uzbay T. Effects of olanzapine on ethanol withdrawal syndrome in rats. European Journal of Pharmacology 2008, 579:208-214.
230. Varty G.B., Bakshi V.P., Geyer M.A. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats. Neuropsychopharmacology 1999, 20:311-321.
231. Vertes R.P. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. Journal of Comparative Neurology 1991, 313:643-668.
232. Wan F.J., Geyer M.A., Swerdlow N.R. Presynaptic dopamine-glutamate interactions in the nucleus accumbens regulate sensorimotor gating. Psychopharmacology (Berlin) 1995, 120:433-441.
233. Wan F.J., Swerdlow N.R. Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions. Brain Research 1996, 722:168-176.
234. Wang Z., Maia T.V., Marsh R., Colibazzi T., Gerber A., Peterson B.S. The neural circuits that generate tics in Tourette's syndrome. American Journal of Psychiatry 2011, 168:1326-1337.
235. Weiss I.C., Feldon J. Environmental animal models for sensorimotor gating deficiencies in schizophrenia: a review. Psychopharmacology (Berlin) 2001, 156:305-326.
236. Welter M.L., Mallet L., Houeto J.L., Karachi C., Czernecki V., Cornu P., Navarro S., Pidoux B., Dormont D., Bardinet E., Yelnik J., Damier P., Agid Y. Internal pallidal and thalamic stimulation in patients with Tourette syndrome. Archives of Neurology 2008, 65:952-957.
237. Williams S.F., Herberg L.J. Motivational vs. motor effects of striatal and pallidal gabergic projections to subthalamic and entopeduncular nuclei, ventromedial thalamus, and ventral globus pallidus. Pharmacology Biochemistry & Behavior 1987, 26:49-55.
238. Wilson C.J. GABAergic inhibition in the neostriatum. Progress in Brain Research GABA and the Basal Ganglia - From Molecules to Systems 2007, 91-110. Elsevier. J.M. Tepper (Ed.).
239. Wilson C.J., Groves P.M. Fine structure and synaptic connections of the common spiny neuron of the rat neostriatum: a study employing intracellular inject of horseradish peroxidase. Journal of Comparative Neurology 1980, 194:599-615.
240. Wise R.A. Dopamine, learning and motivation. Nature Reviews Neuroscience 2004, 5:483-494.
241. Wisniecki A., Correa M., Arizzi M.N., Ishiwari K., Salamone J.D. Motor effects of GABA(A) antagonism in globus pallidus: studies of locomotion and tremulous jaw movements in rats. Psychopharmacology (Berlin) 2003, 170:140-149.
242. Wolf S.S., Jones D.W., Knable M.B., Gorey J.G., Lee K.S., Hyde T.M., Coppola R., Weinberger D.R. Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 1996, 273:1225-1227.
243. Wong D.F., Brasic J.R., Singer H.S., Schretlen D.J., Kuwabara H., Zhou Y., Nandi A., Maris M.A., Alexander M., Ye W., Rousset O., Kumar A., Szabo Z., Gjedde A., Grace A.A. Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology 2008, 33:1239-1251.
244. Wong D.F., Singer H.S., Brandt J., Shaya E., Chen C., Brown J., Kimball A.W., Gjedde A., Dannals R.F., Ravert H.T., Wilson P.D., Wagner H.N. D2-like dopamine receptor density in Tourette syndrome measured by PET. Journal of Nuclear Medicine 1997, 38:1243-1247.
245. Worbe Y., Baup N., Grabli D., Chaigneau M., Mounayar S., McCairn K., Feger J., Tremblay L. Behavioral and movement disorders induced by local inhibitory dysfunction in primate striatum. Cerebral Cortex 2009, 19:1844-1856.
246. Yee B.K., Russig H., Feldon J. Apomorphine-induced prepulse inhibition disruption is associated with a paradoxical enhancement of prepulse stimulus reactivity. Neuropsychopharmacology 2004, 29:240-248.
247. Yeomans J.S., Bosch D., Alves N., Daros A., Ure R.J., Schmid S. GABA receptors and prepulse inhibition of acoustic startle in mice and rats. European Journal of Neuroscience 2010, 31:2053-2061.
248. Zhuang P., Hallett M., Zhang X., Li J., Zhang Y., Li Y. Neuronal activity in the globus pallidus internus in patients with tics. Journal of Neurology, Neurosurgery and Psychiatry 2009.
249. Ziemann U., Paulus W., Rothenberger A. Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation. American Journal of Psychiatry 1997, 154:1277-1284.
250. Zohar J., Chopra M., Sasson Y., Amiaz R., Amital D. Obsessive compulsive disorder: serotonin and beyond. World Journal of Biological Psychiatry 2000, 1:92-100.